It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HALO’s FA Score shows that 1 FA rating(s) are green whileKZR’s FA Score has 1 green FA rating(s), and PRQR’s FA Score reflects 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HALO’s TA Score shows that 3 TA indicator(s) are bullish while KZR’s TA Score has 6 bullish TA indicator(s), and PRQR’s TA Score reflects 4 bullish TA indicator(s).
HALO (@Biotechnology) experienced а -1.30% price change this week, while KZR (@Biotechnology) price change was -12.79% , and PRQR (@Biotechnology) price fluctuated +6.59% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.
HALO is expected to report earnings on Aug 12, 2025.
KZR is expected to report earnings on May 13, 2025.
PRQR is expected to report earnings on Jul 31, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
HALO | KZR | PRQR | |
Capitalization | 6.55B | 32.6M | 204M |
EBITDA | 705M | -76.06M | -26.88M |
Gain YTD | 11.169 | -39.137 | -26.792 |
P/E Ratio | 14.14 | N/A | N/A |
Revenue | 1.08B | 0 | 19M |
Total Cash | 748M | 114M | 132M |
Total Debt | 1.51B | 14.1M | 16.9M |
HALO | KZR | PRQR | ||
---|---|---|---|---|
OUTLOOK RATING 1..100 | 74 | 12 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 75 Overvalued | 12 Undervalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 41 | 100 | 100 | |
SMR RATING 1..100 | 12 | 97 | 97 | |
PRICE GROWTH RATING 1..100 | 57 | 65 | 47 | |
P/E GROWTH RATING 1..100 | 86 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 95 | 65 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KZR's Valuation (12) in the Biotechnology industry is in the same range as PRQR (34) and is somewhat better than the same rating for HALO (75). This means that KZR's stock grew similarly to PRQR’s and somewhat faster than HALO’s over the last 12 months.
HALO's Profit vs Risk Rating (41) in the Biotechnology industry is somewhat better than the same rating for KZR (100) and is somewhat better than the same rating for PRQR (100). This means that HALO's stock grew somewhat faster than KZR’s and somewhat faster than PRQR’s over the last 12 months.
HALO's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for KZR (97) and is significantly better than the same rating for PRQR (97). This means that HALO's stock grew significantly faster than KZR’s and significantly faster than PRQR’s over the last 12 months.
PRQR's Price Growth Rating (47) in the Biotechnology industry is in the same range as HALO (57) and is in the same range as KZR (65). This means that PRQR's stock grew similarly to HALO’s and similarly to KZR’s over the last 12 months.
HALO's P/E Growth Rating (86) in the Biotechnology industry is in the same range as PRQR (100) and is in the same range as KZR (100). This means that HALO's stock grew similarly to PRQR’s and similarly to KZR’s over the last 12 months.
HALO | KZR | PRQR | |
---|---|---|---|
RSI ODDS (%) | N/A | 2 days ago90% | N/A |
Stochastic ODDS (%) | 2 days ago66% | 2 days ago88% | 2 days ago85% |
Momentum ODDS (%) | 2 days ago68% | 2 days ago72% | 2 days ago85% |
MACD ODDS (%) | 2 days ago64% | 2 days ago89% | 2 days ago69% |
TrendWeek ODDS (%) | 2 days ago69% | 2 days ago88% | 2 days ago83% |
TrendMonth ODDS (%) | 2 days ago74% | 2 days ago81% | 2 days ago82% |
Advances ODDS (%) | 8 days ago77% | 8 days ago72% | 8 days ago85% |
Declines ODDS (%) | 3 days ago68% | 3 days ago90% | 10 days ago86% |
BollingerBands ODDS (%) | N/A | 2 days ago90% | 2 days ago89% |
Aroon ODDS (%) | N/A | 2 days ago89% | 2 days ago82% |
A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.
Ticker / NAME | Correlation To HALO | 1D Price Change % | ||
---|---|---|---|---|
HALO | 100% | +0.08% | ||
AXON - HALO | 47% Loosely correlated | -0.87% | ||
XENE - HALO | 45% Loosely correlated | +0.63% | ||
VIR - HALO | 40% Loosely correlated | +2.16% | ||
ARGX - HALO | 36% Loosely correlated | -0.52% | ||
TECH - HALO | 34% Loosely correlated | +1.27% | ||
More |
A.I.dvisor indicates that over the last year, KZR has been loosely correlated with AMRN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then AMRN could also see price increases.
Ticker / NAME | Correlation To KZR | 1D Price Change % | ||
---|---|---|---|---|
KZR | 100% | N/A | ||
AMRN - KZR | 56% Loosely correlated | -0.60% | ||
CNTB - KZR | 47% Loosely correlated | -7.40% | ||
SAGE - KZR | 36% Loosely correlated | +0.11% | ||
RAPT - KZR | 34% Loosely correlated | -5.36% | ||
CTMX - KZR | 34% Loosely correlated | -11.34% | ||
More |
A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with WVE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then WVE could also see price increases.
Ticker / NAME | Correlation To PRQR | 1D Price Change % | ||
---|---|---|---|---|
PRQR | 100% | +2.65% | ||
WVE - PRQR | 59% Loosely correlated | +4.70% | ||
KRRO - PRQR | 59% Loosely correlated | -1.11% | ||
ATNF - PRQR | 55% Loosely correlated | -5.26% | ||
ENVB - PRQR | 43% Loosely correlated | +0.80% | ||
VYGR - PRQR | 34% Loosely correlated | -2.56% | ||
More |